Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 8:06 PM View:  | Akero Therapeutics, Inc. (AKRO) | 15-Oct-24 | Option Exercise | 14,825 | $0.62 | $9,117.38 | 20% 75.29K to 90.12K | |
| 16-Oct-24 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Oct-24 | Planned Option Sale | 13,689 | $30.50 | $417,579.00 | (15%) 90.12K to 76.43K | |
| 16-Oct-24 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Oct-24 | Sale (Planned) | 1,136 | $30.50 | $34,653.40 | (1%) 76.43K to 75.29K | |
| 16-Oct-24 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Oct-24 | Option Exercise | 5,000 | $0.62 | $3,075.00 | 7% 75.29K to 80.29K | |
| 16-Oct-24 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Oct-24 | Planned Option Sale | 6,136 | $30.03 | $184,258.00 | (8%) 80.29K to 74.16K | |
| 23-Sep-24 6:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 20-Sep-24 | Option Exercise | 5,500 | $0.62 | $3,382.50 | 7% 75.29K to 80.79K | |
| 23-Sep-24 6:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 20-Sep-24 | Planned Option Sale | 5,500 | $27.65 | $152,086.00 | (7%) 80.79K to 75.29K | |
| 13-Sep-24 5:14 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Sep-24 | Private Sale | 637 | $26.18 | $16,676.70 | (< 1%) 75.93K to 75.29K | |
| 05-Sep-24 4:05 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Sep-24 | Option Exercise | 949 | $0.62 | $583.64 | 1% 75.93K to 76.88K | |
| 05-Sep-24 4:05 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Sep-24 | Planned Option Sale | 949 | $27.61 | $26,205.70 | (1%) 76.88K to 75.93K | |
| 28-Aug-24 11:11 AM View: | Akero Therapeutics, Inc. (AKRO) | 26-Aug-24 | Option Exercise | 5,200 | $0.62 | $3,198.00 | 7% 75.93K to 81.13K | |
| 28-Aug-24 11:11 AM View: | Akero Therapeutics, Inc. (AKRO) | 26-Aug-24 | Planned Option Sale | 5,200 | $27.51 | $143,073.00 | (6%) 81.13K to 75.93K | |
| 28-Aug-24 11:11 AM View: | Akero Therapeutics, Inc. (AKRO) | 23-Aug-24 | Option Exercise | 8,851 | $0.62 | $5,443.37 | 12% 75.93K to 84.78K | |
| 28-Aug-24 11:11 AM View: | Akero Therapeutics, Inc. (AKRO) | 23-Aug-24 | Planned Option Sale | 8,851 | $27.53 | $243,641.00 | (10%) 84.78K to 75.93K | |
| 13-Jun-24 6:11 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Jun-24 | Private Sale | 2,825 | $22.64 | $63,960.80 | (4%) 77.69K to 74.87K | |
| 15-Mar-24 4:45 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Mar-24 | Private Sale | 723 | $28.33 | $20,482.60 | (< 1%) 78.42K to 77.69K | |
| 06-Mar-24 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Mar-24 | Option Exercise | 20,646 | $13.96 | $288,124.00 | 26% 78.42K to 99.06K | |
| 06-Mar-24 10:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Mar-24 | Planned Option Sale | 20,646 | $35.49 | $732,727.00 | (21%) 99.06K to 78.42K | |
| 18-Dec-23 8:49 PM View: | Akero Therapeutics, Inc. (AKRO) | 14-Dec-23 | Market Sale | 597 | $20.76 | $12,393.70 | (< 1%) 78.51K to 77.91K | 5% |
| 12-Dec-23 4:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Dec-23 | Grant | 32,497 | -- | -- | 71% 46.01K to 78.51K | |
| 25-Sep-23 8:31 PM View: | Akero Therapeutics, Inc. (AKRO) | 21-Sep-23 | Option Exercise | 5,000 | $6.36 | $31,800.00 | 11% 46.01K to 51.01K | |
| 25-Sep-23 8:31 PM View: | Akero Therapeutics, Inc. (AKRO) | 21-Sep-23 | Planned Option Sale | 4,383 | $48.07 | $210,696.00 | (9%) 51.01K to 46.63K | |
| 25-Sep-23 8:31 PM View: | Akero Therapeutics, Inc. (AKRO) | 21-Sep-23 | Sale (Planned) | 617 | $48.07 | $29,659.90 | (1%) 46.63K to 46.01K | |
| 25-Sep-23 8:31 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-23 | Planned Private Option Sale | 617 | $50.34 | $31,059.80 | (1%) 46.63K to 46.01K | |
| 30-Aug-23 7:04 PM View: | Akero Therapeutics, Inc. (AKRO) | 28-Aug-23 | Option Exercise | 5,745 | $6.36 | $36,538.20 | 12% 46.63K to 52.37K | |
| 30-Aug-23 7:04 PM View: | Akero Therapeutics, Inc. (AKRO) | 28-Aug-23 | Planned Option Sale | 5,745 | $49.99 | $287,191.00 | (11%) 52.37K to 46.63K | |
| 23-Jun-23 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 23-Jun-23 | Sale | 11,000 | $50.76 | $558,360.00 | (19%) 57.63K to 46.63K | |
| 23-Jun-23 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 22-Jun-23 | Sale | 11,000 | $52.18 | $573,935.00 | (16%) 68.63K to 57.63K | |
| 23-Jun-23 8:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 21-Jun-23 | Private Sale | 11,349 | $52.26 | $593,095.00 | (14%) 79.98K to 68.63K | |
| 15-Jun-23 9:29 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jun-23 | Private Sale (Planned) | 591 | $55.16 | $32,599.60 | (< 1%) 80.57K to 79.98K | |
| 14-Mar-23 4:20 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Mar-23 | Payment of Exercise | 701 | $43.46 | $30,465.50 | (< 1%) 81.27K to 80.57K | |
| 18-Jan-23 5:30 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jan-23 | Private Sale (Planned) | 5,000 | $50.53 | $252,651.00 | (6%) 86.27K to 81.27K | |
| 13-Dec-22 8:24 PM View: | Akero Therapeutics, Inc. (AKRO) | 12-Dec-22 | Sale (Planned) | 5,000 | $43.23 | $216,137.00 | (5%) 91.27K to 86.27K | |
| 13-Dec-22 8:24 PM View: | Akero Therapeutics, Inc. (AKRO) | 09-Dec-22 | Grant | 19,195 | -- | -- | 27% 72.07K to 91.27K | |
| 14-Nov-22 5:26 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Nov-22 | Private Sale (Planned) | 5,000 | $39.42 | $197,105.00 | (6%) 77.07K to 72.07K | |
| 12-Oct-22 4:59 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Oct-22 | Private Sale (Planned) | 5,000 | $37.99 | $189,950.00 | (6%) 82.07K to 77.07K | |
| 15-Sep-22 7:59 PM View: | Akero Therapeutics, Inc. (AKRO) | 13-Sep-22 | Private Sale (Planned) | 40,000 | $27.48 | $1,099,230.00 | (33%) 122.07K to 82.07K | |
| 13-Sep-22 9:15 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-22 | Grant | 1,152 | $8.03 | $9,250.56 | < 1% 120.92K to 122.07K | |
| 18-Oct-21 4:21 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Oct-21 | Market Sale (Planned) | 12,500 | $21.59 | $269,826.00 | (9%) 133.42K to 120.92K | 1% |
| 17-Aug-21 9:15 PM View: | Akero Therapeutics, Inc. (AKRO) | 16-Aug-21 | Market Sale (Planned) | 10,000 | $18.79 | $187,900.00 | (6%) 155.92K to 145.92K | (< 1%) |
| 19-Jul-21 4:43 PM View: | Akero Therapeutics, Inc. (AKRO) | 15-Jul-21 | Market Sale (Planned) | 10,000 | $20.90 | $209,044.00 | (6%) 165.92K to 155.92K | (7%) |
| 09-Dec-20 8:50 PM View: | Akero Therapeutics, Inc. (AKRO) | 30-Jun-20 | Grant | 1,245 | $17.07 | $21,249.70 | < 1% 163.67K to 164.91K | |
| 03-Jan-20 6:16 PM View: | Akero Therapeutics, Inc. (AKRO) | 31-Dec-19 | Grant | 1,025 | $18.87 | $19,337.60 | < 1% 162.64K to 163.67K |